Fampridine is the active ingredient of the drug "Fampira". It is a potassium channel blocker that prevents the loss of potassium by nerve cells. This restores the normal transmission of signals between nerve endings, which improves the patient's movement and balance.

Release form: 10 mg tablets in a pack of 100 pieces.

Indications for use

"Fampira" is used for the symptomatic treatment of walking disorders in adults with multiple sclerosis (with a score of 4-7 on the extended EDSS scale). The drug can be used alone or in combination with other medications.

Contraindications

The drug is not recommended for:

• hypersensitivity to fampridine;
• simultaneous administration of different forms of fampridine or 4-aminopyridine;
• having seizures in the past;
• renal insufficiency (creatinine clearance <80 ml/min);
• use of drugs that block OST2 (for example, cimetidine);
• under the age of 18.

Pregnant and lactating women should take the drug with caution.

Method of application and dosage

Recommended dose: one tablet (10 mg) twice a day with an interval of 12 hours (morning and evening). Do not exceed the indicated dosage.

Reception features:

• Tablets should be swallowed whole, not chewed or broken.
• If you miss a dose, do not take a double dose.
• It is recommended to start treatment for 2-4 weeks. If there is no improvement after this period, the drug should be discontinued.

Side effects

Possible side effects:

• urinary tract infections;
• insomnia, anxiety, dizziness, headache, imbalance, numbness, tremor;
• rapid heartbeat;
• shortness of breath, sore throat;
• nausea, vomiting, constipation;
• back pain;
• Weakness.